SGLT inhibitors as antidiabetic agents: a comprehensive review

Diabetes is one of the most common disorders that substantially contributes to an increase in global health burden. As a metabolic disorder, diabetes is associated with various medical conditions and diseases such as obesity, hypertension, cardiovascular diseases, and atherosclerosis. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales: Kshirsagar, Rahul P., Kulkarni, Abhishek A., Chouthe, Rashmi S., Pathan, Shahebaaz K., Une, Hemant D., Reddy, G. Bhanuprakash, Diwan, Prakash V., Ansari, Siddique Akber, Sangshetti, Jaiprakash N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048284/
https://www.ncbi.nlm.nih.gov/pubmed/35494673
http://dx.doi.org/10.1039/c9ra08706k
Descripción
Sumario:Diabetes is one of the most common disorders that substantially contributes to an increase in global health burden. As a metabolic disorder, diabetes is associated with various medical conditions and diseases such as obesity, hypertension, cardiovascular diseases, and atherosclerosis. In this review, we cover the scientific studies on sodium/glucose cotransporter (SGLT) inhibitors published during the last decade. Our focus on providing an exhaustive overview of SGLT inhibitors enabled us to present their chemical classification for the first time.

Ejemplares similares